BioNexus Gene Lab Corp Common stock (BGLC) — Free Cash Flow Generation Index
BioNexus Gene Lab Corp Common stock (BGLC) has a Free Cash Flow Generation Index of 0.96x as of December 2022. Free cash flow of $457.44K represents 1% of operating cash flow ($474.47K). See BioNexus Gene Lab Corp Common stock current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
BioNexus Gene Lab Corp Common stock Free Cash Flow Generation Index (2017–2022)
Historical FCF Generation Index trend for BioNexus Gene Lab Corp Common stock across 4 annual periods. Explore BGLC debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for BioNexus Gene Lab Corp Common stock (2017–2022)
Year-by-year Free Cash Flow Generation Index for BioNexus Gene Lab Corp Common stock. For the full company profile including market capitalisation, see BioNexus Gene Lab Corp Common stock (BGLC) total market value.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.90x | $489.86K | $544.03K | $54.17K | ▲ +37.5% |
| 2021 | 0.65x | $6.00K | $9.16K | $3.16K | ▲ +176.1% |
| 2020 | 0.24x | $131.06K | $552.68K | $421.62K | ▲ +99.8% |
| 2017 | 0.12x | $42.40K | $357.22K | $314.82K | — |